Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythromycin effects on multiple-dose carbamazepine kinetics.

M V Miles1, M B Tennison

  • 1Department of Pharmacy Practice, School of Pharmacy, University of North Carolina, Chapel Hill 27599.

Therapeutic Drug Monitoring
|January 1, 1989
PubMed
Summary

Erythromycin significantly alters carbamazepine pharmacokinetics, increasing its half-life and blood levels. This drug interaction, affecting carbamazepine metabolism, shows high individual variability, warning clinicians of unpredictable effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis.

Alimentary pharmacology & therapeutics·2016
Same author

Massive expansion of SCA2 with autonomic dysfunction, retinitis pigmentosa, and infantile spasms.

Neurology·2011
Same author

HPLC analysis of reduced and oxidized coenzyme Q(10) in human plasma.

Clinical chemistry·2001
Same author

An improved gas chromatography assay for topiramate monitoring in pediatric patients.

Therapeutic drug monitoring·2000
Same author

When to start and stop anticonvulsant therapy in children.

Archives of neurology·1999
Same author

Topiramate pharmacokinetics in infants.

Epilepsia·1999

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Clinical Pharmacy

Background:

  • Carbamazepine is an anticonvulsant and mood-stabilizing drug.
  • Erythromycin is a macrolide antibiotic.
  • Understanding drug-drug interactions is crucial for patient safety.

Purpose of the Study:

  • To investigate the pharmacokinetic effects of erythromycin on multiple-dose carbamazepine administration.
  • To assess the impact of erythromycin on carbamazepine and its epoxide metabolite levels.

Main Methods:

  • Seven healthy male volunteers received carbamazepine for 17 days.
  • Erythromycin or placebo was administered during the final days of carbamazepine dosing.
  • Serial blood samples were analyzed for carbamazepine and carbamazepine-10,11-epoxide using high-performance liquid chromatography.

Related Experiment Videos

Main Results:

  • Erythromycin significantly increased carbamazepine half-life and 24-h postdose concentrations.
  • Oral clearance of carbamazepine decreased significantly during erythromycin administration.
  • Erythromycin inhibited the epoxide-diol metabolic pathway, reducing carbamazepine-10,11-epoxide levels and ratios.

Conclusions:

  • Erythromycin significantly alters carbamazepine pharmacokinetics by inhibiting its metabolism.
  • The interaction between erythromycin and carbamazepine exhibits considerable individual variability.
  • Clinicians should be aware of the potential for unpredictable interactions when co-prescribing these drugs.